Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology
Literature
1.
Metra M, Torp-Pedersen C, Swedberg K, Cleland JG, DiLenarda A, Komajda M, Remme WJ, Lutiger B, Schgerhag A, Lukas MA, Charlesworth A, Poole-Wilson PA (2005) Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 26:2259–2268PubMedCrossRef
2.
Lechat P, Hulot JS, Escolano S, Mallet A, Leizorovicz A, Werhlen-Grandjean M, Pochmalicki G, Dargie H (2001) Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103:1428–1433PubMed
3.
Peterson JW, Felker M (2008) Inotropes in the management of acute heart failure. Crit Care Med 36:S106–S111CrossRef
4.
Eklayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV (2007) Use and impact of inotropes and vasodilatatory therapy in hospitalized patients with severe heart failure. Am Heart J 153:98–104CrossRef
5.
Simon L, Ghalch B, Puybasset L, Giudicelli JF, Berdeaux A (1995) Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 275:659–666PubMed
6.
Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators Group (2003) Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107:817–823PubMedCrossRef
7.
Fox K, Ferrari R, Tendera M, Steg PG, Ford I, BEAUTIFUL Steering Committee (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary heart disease and left ventricular systolic dysfunction: the morbidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction (BEAUTIFUL) Study. Am Heart J 152:860–866PubMedCrossRef
8.
De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L (2008) Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail 10:550–555PubMedCrossRef
9.
Hoppe UC, La Rosée K, Larbig R, Erdmann E (2007) Selective inhibition of the pacemaker channel I(f) improves symptoms in severe dilated cardiomyopathy. Clin Res Cardiol 96:243–246PubMedCrossRef
10.
Reil JC, Böhm M (2007) The role of heart rate in the development of cardiovascular disease. Clin Res Cardiol 96:585–592PubMedCrossRef
Metadata
Title
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure
Authors
Andreas Link
Jan Christian Reil
Simina Selejan
Michael Böhm
Publication date
01-08-2009
Publisher
D. Steinkopff-Verlag
Published in
Clinical Research in Cardiology / Issue 8/2009
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-009-0038-9

Other articles of this Issue 8/2009

Clinical Research in Cardiology 8/2009 Go to the issue

Clinical Correspondence

Loss of capture late after right ventricular pacing lead revision: what is the mechanism?

Original Paper

Enhanced mobilization of CD34+ progenitor cells expressing cell adhesion molecules in patients with STEMI

Original Paper

Right ventricular rapid pacing in catheter ablation of atrial fibrillation: a novel application for cryoballoon pulmonary vein isolation

Original Paper

Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failure

Clinical Correspondence

A rare cause of sudden cardiac arrest: primary cardiac lymphoma

Original Paper

Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits